Cargando…

Myostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy

Lipodystrophies are characterized by a loss of white adipose tissue, which causes ectopic lipid deposition, peripheral insulin resistance, reduced adipokine levels, and increased food intake (hyperphagia). The growth factor myostatin (MSTN) negatively regulates skeletal muscle growth, and mice with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tingqing, Bond, Nichole D., Jou, William, Gavrilova, Oksana, Portas, Jennifer, McPherron, Alexandra C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447905/ https://www.ncbi.nlm.nih.gov/pubmed/22596054 http://dx.doi.org/10.2337/db11-0915

Ejemplares similares

Myostatin inhibition improves hyperglycemia and hyperphagia in lipodystrophic mice
por: Guo, Tingqing, et al.
Publicado: (2012)

Myostatin Inhibition in Muscle, but Not Adipose Tissue, Decreases Fat Mass and Improves Insulin Sensitivity
por: Guo, Tingqing, et al.
Publicado: (2009)

Increasing muscle mass to improve metabolism
por: McPherron, Alexandra C., et al.
Publicado: (2013)

Inhibition of myostatin signaling increases glucose in insulin-deficient diabetic mice
por: Wang, Qian, et al.
Publicado: (2012)

A Soluble Activin Receptor Type IIB Does Not Improve Blood Glucose in Streptozotocin-Treated Mice
por: Wang, Qian, et al.
Publicado: (2015)

Redundancy of myostatin and growth/differentiation factor 11 function
por: McPherron, Alexandra C, et al.
Publicado: (2009)

Modeling Energy Dynamics in Mice with Skeletal Muscle Hypertrophy Fed High Calorie Diets
por: Bond, Nichole D., et al.
Publicado: (2016)

Effects of serotonin on skeletal muscle growth
por: Chandran, Suchismita, et al.
Publicado: (2012)

The Human Lipodystrophy Gene BSCL2/Seipin May Be Essential for Normal Adipocyte Differentiation
por: Payne, Victoria A., et al.
Publicado: (2008)

Lipodystrophy Due to Adipose Tissue–Specific Insulin Receptor Knockout Results in Progressive NAFLD
por: Softic, Samir, et al.
Publicado: (2016)

Intact vagal gut‐brain signalling prevents hyperphagia and excessive weight gain in response to high‐fat high‐sugar diet
por: McDougle, Molly, et al.
Publicado: (2020)

Comparison of Dorsocervical With Abdominal Subcutaneous Adipose Tissue in Patients With and Without Antiretroviral Therapy–Associated Lipodystrophy
por: Sevastianova, Ksenia, et al.
Publicado: (2011)

Additional statistical and graphical methods for analyzing site formation processes using artifact orientations
por: McPherron, Shannon P.
Publicado: (2018)

Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2
por: Corsa, Callie A.S., et al.
Publicado: (2021)

SUN-543 Myostatin Inhibits IGF1-Dependent Citrate Production during Osteogenesis in a Mouse Mesenchymal Stem Cell Line
por: Liu, Xin-Hua, et al.
Publicado: (2019)

G(s)α deficiency in the dorsomedial hypothalamus leads to obesity, hyperphagia, and reduced thermogenesis associated with impaired leptin signaling
por: Chen, Min, et al.
Publicado: (2019)

MON-685 Lipodystrophy, a Forgotten Syndrome
por: Castellano, Janet Marie Colón, et al.
Publicado: (2020)

Food Intake and Hypothalamic Hyperphagia
por: Strominger, Jack L., et al.
Publicado: (1953)

THU301 Natural History Of Pregnancy And Pregnancy Outcomes In Subjects With Lipodystrophy
por: Neal, Trinity J, et al.
Publicado: (2023)

CDK4-E2F3 signals enhance oxidative skeletal muscle fiber numbers and function to affect myogenesis and metabolism
por: Bahn, Young Jae, et al.
Publicado: (2023)

PSUN138 Demonstration of Progressive Beta-Cell Failure in Familial Partial Lipodystrophy
por: De Freitas, Maria Foss, et al.
Publicado: (2022)

OR18-04 Leptin Decreases Gluconeogenesis And Gluconeogenic Substrate Availability In Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2023)

Racial Disparities Among Clinical Trials for Inherited Forms of Lipodystrophy
por: Abel, Brent S, et al.
Publicado: (2021)

PSUN141 Suspected Lipodystrophy in a Thin Young Man With Type 1 Diabetes
por: Moats, Sarah, et al.
Publicado: (2022)

Experimental Hypothalamic Hyperphagia in the Albino Rat
por: Brobeck, John R., et al.
Publicado: (1943)

Edge Length and Surface Area of a Blank: Experimental Assessment of Measures, Size Predictions and Utility
por: Dogandžić, Tamara, et al.
Publicado: (2015)

Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
por: Baig, Mohammad Hassan, et al.
Publicado: (2022)

Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader–Willi syndrome
por: Davies, Jennifer R., et al.
Publicado: (2015)

SAT089 Natural History Of Generalized Lipodystrophy Following Early Vs. Late Metreleptin Treatment
por: Brush, Maiah, et al.
Publicado: (2023)

Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy
por: Long, Kimberly K, et al.
Publicado: (2019)

Inflammation, organomegaly, and muscle wasting despite hyperphagia in a mouse model of burn cachexia
por: Pedroso, Felipe E., et al.
Publicado: (2012)

Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome
por: Bindels-de Heus, Karen G. C. B., et al.
Publicado: (2023)

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice
por: Bondulich, Marie K., et al.
Publicado: (2017)

OR08-04 Differences in Advanced Lipoprotein Profile Between Rabson-Mendenhall Syndrome and Lipodystrophy
por: Al-Jundi, Mohammad, et al.
Publicado: (2020)

Not Enough Fat: Mouse Models of Inherited Lipodystrophy
por: Le Lay, Soazig, et al.
Publicado: (2022)

Body Composition And Bone Mineral Differences According to Lamin A (LMNA) Genotype in Familial Partial Lipodystrophy Type 2
por: de Freitas, Maria Cristina Foss, et al.
Publicado: (2021)

SAT090 Serum Ketone Levels Are Disproportionate To Beta-Oxidation In Insulin Receptor Mutation Compared Vs Lipodystrophy Patients
por: Klein, Rachael, et al.
Publicado: (2023)

Medication Trials for Hyperphagia and Food-Related Behaviors in Prader–Willi Syndrome
por: Miller, Jennifer L., et al.
Publicado: (2015)

Burden of hyperphagia and obesity in Bardet–Biedl syndrome: a multicountry survey
por: Forsythe, Elizabeth, et al.
Publicado: (2023)

Hypermetabolism, Hyperphagia, and Reduced Adiposity in Tankyrase-Deficient Mice
por: Yeh, Tsung-Yin J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_139u8qnt5ggd65snutust4m1ui